499 related articles for article (PubMed ID: 15474452)
21. Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization.
Yang XM; Wang YS; Zhang J; Li Y; Xu JF; Zhu J; Zhao W; Chu DK; Wiedemann P
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1873-9. PubMed ID: 19098317
[TBL] [Abstract][Full Text] [Related]
22. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.
Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC
Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035
[TBL] [Abstract][Full Text] [Related]
23. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells.
Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH
Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555
[TBL] [Abstract][Full Text] [Related]
24. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
25. Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1.
Jiang BH; Jiang G; Zheng JZ; Lu Z; Hunter T; Vogt PK
Cell Growth Differ; 2001 Jul; 12(7):363-9. PubMed ID: 11457733
[TBL] [Abstract][Full Text] [Related]
26. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
27. 12-Deoxyphorbol 13-palmitate inhibits the expression of VEGF and HIF-1α in MCF-7 cells by blocking the PI3K/Akt/mTOR signaling pathway.
Yang Y; Cong H; Han C; Yue L; Dong H; Liu J
Oncol Rep; 2015 Oct; 34(4):1755-60. PubMed ID: 26239613
[TBL] [Abstract][Full Text] [Related]
28. Arsenite induces HIF-1alpha and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells.
Gao N; Shen L; Zhang Z; Leonard SS; He H; Zhang XG; Shi X; Jiang BH
Mol Cell Biochem; 2004 Jan; 255(1-2):33-45. PubMed ID: 14971644
[TBL] [Abstract][Full Text] [Related]
29. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation.
Alam H; Maizels ET; Park Y; Ghaey S; Feiger ZJ; Chandel NS; Hunzicker-Dunn M
J Biol Chem; 2004 May; 279(19):19431-40. PubMed ID: 14982927
[TBL] [Abstract][Full Text] [Related]
30. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
[TBL] [Abstract][Full Text] [Related]
31. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways.
Park SH; Kim BR; Lee JH; Park ST; Lee SH; Dong SM; Rho SB
Cell Signal; 2014 Jul; 26(7):1506-13. PubMed ID: 24686084
[TBL] [Abstract][Full Text] [Related]
32. Sp1 is involved in Akt-mediated induction of VEGF expression through an HIF-1-independent mechanism.
Pore N; Liu S; Shu HK; Li B; Haas-Kogan D; Stokoe D; Milanini-Mongiat J; Pages G; O'Rourke DM; Bernhard E; Maity A
Mol Biol Cell; 2004 Nov; 15(11):4841-53. PubMed ID: 15342781
[TBL] [Abstract][Full Text] [Related]
33. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway.
Treins C; Giorgetti-Peraldi S; Murdaca J; Semenza GL; Van Obberghen E
J Biol Chem; 2002 Aug; 277(31):27975-81. PubMed ID: 12032158
[TBL] [Abstract][Full Text] [Related]
34. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
García-Maceira P; Mateo J
Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
[TBL] [Abstract][Full Text] [Related]
35. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
36. Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway.
Kim CH; Cho YS; Chun YS; Park JW; Kim MS
Circ Res; 2002 Feb; 90(2):E25-33. PubMed ID: 11834720
[TBL] [Abstract][Full Text] [Related]
37. VEGF production by primary human renal proximal tubular cells: requirement of HIF-1, PI3-kinase and MAPKK-1 signaling.
Hellwig-Bürgel T; Stiehl DP; Katschinski DM; Marxsen J; Kreft B; Jelkmann W
Cell Physiol Biochem; 2005; 15(1-4):99-108. PubMed ID: 15665520
[TBL] [Abstract][Full Text] [Related]
38. Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha.
Akeno N; Robins J; Zhang M; Czyzyk-Krzeska MF; Clemens TL
Endocrinology; 2002 Feb; 143(2):420-5. PubMed ID: 11796494
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer.
Han JY; Oh SH; Morgillo F; Myers JN; Kim E; Hong WK; Lee HY
J Natl Cancer Inst; 2005 Sep; 97(17):1272-86. PubMed ID: 16145048
[TBL] [Abstract][Full Text] [Related]
40. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.
Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML
Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]